ADD CONDITION
Citroma
Last content change checked dailysee data sync status
- Active ingredient
- Magnesium Citrate 1.745 g/29.6 mL
- Other brand names
- Citroma (by Better Living Brands Llc)
- Citroma (by Better Living Brands Llc)
- Citroma (by C. D. M. a. , Inc)
- Citroma (by Cdma)
- Citroma (by Cdma)
- Citroma (by Consumer Product Partners, Llc)
- Citroma (by Consumer Product Partners, Llc)
- Citroma (by Consumer Product Partners, Llc)
- Citroma (by Cvs Pharmacy, Inc.)
- Citroma (by Cvs Pharmacy, Inc.)
- Citroma (by Discount Drug Mart)
- Citroma (by Geiss, Destin & Dunn, Inc.)
- Citroma (by Midwood Brands, Llc)
- Citroma (by Midwood Brands, Llc)
- Citroma (by Old East Main Co)
- Citroma (by Old East Main Co)
- Citroma (by Old East Main Co.)
- Citroma (by Perrigo Direct, Inc.)
- Citroma (by Perrigo Direct, Inc.)
- Citroma (by Pharmacy Value Alliance Llc)
- Citroma (by Retail Business Services, Llc)
- Citroma (by Retail Business Services, Llc )
- Citroma (by Rite Aid Corporation)
- Citroma (by Rite Aid Corporation)
- Citroma (by Topco Associates Llc)
- Citroma (by Topco Associates Llc)
- Citroma (by United Natural Foods, Inc. Dba Unfi)
- Citroma (by United Natural Foods, Inc. Dba Unfi)
- Citroma (by Uplift Brands, Llc)
- Citroma (by Uplift Brands, Llc)
- Citroma (by Uplift Brands, Llc)
- Citroma (by Valu Merchandisers Company)
- Citroma (by Valu Merchandisers Company)
- Citroma (by Vi-Jon, Llc)
- Citroma (by Vi-Jon, Llc)
- Citroma (by Vi-Jon, Llc)
- Citroma (by Western Family Foods, Inc)
- Ez2go Magnesium Citrate Saline Laxative Lemon Flavor (by Valley Medical Products Llc)
- Gadavyt (by Gadal Laboratories Inc)
- Gadavyt (by Gadal Laboratories Inc)
- Gadavyt (by Gadal Laboratories Inc)
- Magnesium Citrate (by 4 Visions Llc)
- Magnesium Citrate (by Aarna Usa Inc.)
- Magnesium Citrate (by Akron Pharma Inc)
- Magnesium Citrate (by Amerisource Bergen)
- Magnesium Citrate (by Amerisource Bergen)
- Magnesium Citrate (by Bionpharma, Inc.)
- Magnesium Citrate (by Bionpharma, Inc.)
- Magnesium Citrate (by Bionpharma, Inc.)
- Magnesium Citrate (by Bionpharma, Inc.)
- Magnesium Citrate (by Cardinal Health, Inc. 063997360)
- Magnesium Citrate (by Cardinal Health, Inc. 063997360)
- Magnesium Citrate (by Cardinal Health, Inc. 063997360)
- Magnesium Citrate (by Cdma)
- Magnesium Citrate (by Cvs Pharmacy, Inc.)
- Magnesium Citrate (by Cvs Pharmacy, Inc.)
- Magnesium Citrate (by Cvs Pharmacy, Inc.)
- Magnesium Citrate (by Cvs Pharmacy, Inc.)
- Magnesium Citrate (by Harris Teeter, Llc)
- Magnesium Citrate (by Hy-Vee, Inc.)
- Magnesium Citrate (by Kroger Co)
- Magnesium Citrate (by Kroger Co.)
- Magnesium Citrate (by Major Pharmaceuticals)
- Magnesium Citrate (by Meijer Distribution Inc)
- Magnesium Citrate (by Meijer Distribution Inc)
- Magnesium Citrate (by Meijer Distribution Inc.)
- Magnesium Citrate (by Pharma Nobis, Llc)
- Magnesium Citrate (by Pharma Nobis, Llc)
- Magnesium Citrate (by Pharma Nobis, Llc)
- Magnesium Citrate (by Pinnacle Rx Llc )
- Magnesium Citrate (by Publix Super Markets, Inc.)
- Magnesium Citrate (by Publix Super Markets, Inc.)
- Magnesium Citrate (by Shield Pharmaceuticals Corp)
- Magnesium Citrate (by Strategic Sourcing Services)
- Magnesium Citrate (by Strategic Sourcing Services)
- Magnesium Citrate (by Valu Merchandisers Company)
- Magnesium Citrate (by Walgreen Company)
- Magnesium Citrate (by Walgreen Company)
- Magnesium Citrate (by Walgreen Company)
- Onelax (by Akron Pharma Inc)
- Onelax (by Akron Pharma Inc)
- Pen Prep (by Pen Prep Llc)
- View full label-group details →
- Drug classes
- Calculi Dissolution Agent, Osmotic Laxative
- Dosage form
- Liquid
- Route
- Oral
- Prescription status
- OTC (over the counter)
- Pregnancy
- See Pregnancy Use Section
- Lactation
- See Lactation Use Section
- Marketed in the U.S.
- Since 2018
- Label revision date
- February 18, 2026
- Drug Information (PDF)
- Prescribing information, PDF file
- Active ingredient
- Magnesium Citrate 1.745 g/29.6 mL
- Other brand names
- Citroma (by Better Living Brands Llc)
- Citroma (by Better Living Brands Llc)
- Citroma (by C. D. M. a. , Inc)
- Citroma (by Cdma)
- Citroma (by Cdma)
- Citroma (by Consumer Product Partners, Llc)
- Citroma (by Consumer Product Partners, Llc)
- Citroma (by Consumer Product Partners, Llc)
- Citroma (by Cvs Pharmacy, Inc.)
- Citroma (by Cvs Pharmacy, Inc.)
- Citroma (by Discount Drug Mart)
- Citroma (by Geiss, Destin & Dunn, Inc.)
- Citroma (by Midwood Brands, Llc)
- Citroma (by Midwood Brands, Llc)
- Citroma (by Old East Main Co)
- Citroma (by Old East Main Co)
- Citroma (by Old East Main Co.)
- Citroma (by Perrigo Direct, Inc.)
- Citroma (by Perrigo Direct, Inc.)
- Citroma (by Pharmacy Value Alliance Llc)
- Citroma (by Retail Business Services, Llc)
- Citroma (by Retail Business Services, Llc )
- Citroma (by Rite Aid Corporation)
- Citroma (by Rite Aid Corporation)
- Citroma (by Topco Associates Llc)
- Citroma (by Topco Associates Llc)
- Citroma (by United Natural Foods, Inc. Dba Unfi)
- Citroma (by United Natural Foods, Inc. Dba Unfi)
- Citroma (by Uplift Brands, Llc)
- Citroma (by Uplift Brands, Llc)
- Citroma (by Uplift Brands, Llc)
- Citroma (by Valu Merchandisers Company)
- Citroma (by Valu Merchandisers Company)
- Citroma (by Vi-Jon, Llc)
- Citroma (by Vi-Jon, Llc)
- Citroma (by Vi-Jon, Llc)
- Citroma (by Western Family Foods, Inc)
- Ez2go Magnesium Citrate Saline Laxative Lemon Flavor (by Valley Medical Products Llc)
- Gadavyt (by Gadal Laboratories Inc)
- Gadavyt (by Gadal Laboratories Inc)
- Gadavyt (by Gadal Laboratories Inc)
- Magnesium Citrate (by 4 Visions Llc)
- Magnesium Citrate (by Aarna Usa Inc.)
- Magnesium Citrate (by Akron Pharma Inc)
- Magnesium Citrate (by Amerisource Bergen)
- Magnesium Citrate (by Amerisource Bergen)
- Magnesium Citrate (by Bionpharma, Inc.)
- Magnesium Citrate (by Bionpharma, Inc.)
- Magnesium Citrate (by Bionpharma, Inc.)
- Magnesium Citrate (by Bionpharma, Inc.)
- Magnesium Citrate (by Cardinal Health, Inc. 063997360)
- Magnesium Citrate (by Cardinal Health, Inc. 063997360)
- Magnesium Citrate (by Cardinal Health, Inc. 063997360)
- Magnesium Citrate (by Cdma)
- Magnesium Citrate (by Cvs Pharmacy, Inc.)
- Magnesium Citrate (by Cvs Pharmacy, Inc.)
- Magnesium Citrate (by Cvs Pharmacy, Inc.)
- Magnesium Citrate (by Cvs Pharmacy, Inc.)
- Magnesium Citrate (by Harris Teeter, Llc)
- Magnesium Citrate (by Hy-Vee, Inc.)
- Magnesium Citrate (by Kroger Co)
- Magnesium Citrate (by Kroger Co.)
- Magnesium Citrate (by Major Pharmaceuticals)
- Magnesium Citrate (by Meijer Distribution Inc)
- Magnesium Citrate (by Meijer Distribution Inc)
- Magnesium Citrate (by Meijer Distribution Inc.)
- Magnesium Citrate (by Pharma Nobis, Llc)
- Magnesium Citrate (by Pharma Nobis, Llc)
- Magnesium Citrate (by Pharma Nobis, Llc)
- Magnesium Citrate (by Pinnacle Rx Llc )
- Magnesium Citrate (by Publix Super Markets, Inc.)
- Magnesium Citrate (by Publix Super Markets, Inc.)
- Magnesium Citrate (by Shield Pharmaceuticals Corp)
- Magnesium Citrate (by Strategic Sourcing Services)
- Magnesium Citrate (by Strategic Sourcing Services)
- Magnesium Citrate (by Valu Merchandisers Company)
- Magnesium Citrate (by Walgreen Company)
- Magnesium Citrate (by Walgreen Company)
- Magnesium Citrate (by Walgreen Company)
- Onelax (by Akron Pharma Inc)
- Onelax (by Akron Pharma Inc)
- Pen Prep (by Pen Prep Llc)
- View full label-group details →
- Drug classes
- Calculi Dissolution Agent, Osmotic Laxative
- Dosage form
- Liquid
- Route
- Oral
- Prescription status
- OTC (over the counter)
- CSA schedule
- Not a scheduled drug
- Pregnancy
- See Pregnancy Use Section
- Lactation
- See Lactation Use Section
- Marketed in the U.S.
- Since 2018
- Label revision date
- February 18, 2026
- Manufacturer
- Target Corporation
- Registration number
- M007
- NDC root
- 11673-708
- Drug Information (PDF)
- Prescribing information, PDF file
If you are a healthcare professional or from the pharmaceutical industry please visit this version.
If you are a consumer or patient please visit this version.
Drug Overview
Magnesium Citrate is a saline laxative that comes in an oral solution, typically flavored with lemon. It is designed to provide relief from occasional constipation, helping to promote regular bowel movements. When taken, it generally works within 30 minutes to 6 hours to help you feel more comfortable and relieve irregularity.
This product is available in a 10 FL OZ (296 mL) bottle, making it easy to use when you need it. If you're experiencing occasional constipation, Magnesium Citrate may be a helpful option to consider for restoring your digestive comfort.
Uses
If you're experiencing occasional constipation (irregularity), this medication can help provide relief. It typically works by encouraging a bowel movement within 30 minutes to 6 hours after taking it, making it a convenient option for those times when you need quick relief.
Rest assured, this medication does not have any known teratogenic effects, meaning it does not cause birth defects. Additionally, there are no reported nonteratogenic effects, so you can feel confident in its safety profile for occasional use.
Dosage and Administration
Before you take your medication, make sure to shake the bottle well. When you're ready to take your dose, drink a full glass (8 ounces) of liquid along with it. You can take your medication either as a single dose each day or split it into smaller doses throughout the day.
For adults and children aged 12 and older, the recommended dose is between 6.5 to 10 fluid ounces, but you should not exceed 10 fluid ounces in a 24-hour period. If your child is between 6 and 12 years old, they should take between 3 to 7 fluid ounces, with a maximum of 7 fluid ounces in a day. For younger children aged 2 to under 6 years, the dose is 2 to 3 fluid ounces, and they should not exceed 3 fluid ounces in a 24-hour period. If your child is under 2 years old, it's important to consult a doctor before giving them this medication.
What to Avoid
It's important to be aware of certain situations where you should stop using this medication and consult your doctor. If you experience rectal bleeding or if you do not have a bowel movement after using the product, these could be signs of a serious condition that requires medical attention.
Currently, there are no specific contraindications, risks of abuse or misuse, or concerns about dependence associated with this medication mentioned in the information provided. However, always prioritize your health and safety by following the guidance of your healthcare provider.
Side Effects
If you experience rectal bleeding or do not have a bowel movement after using this medication, it is important to stop using it and consult your doctor. These symptoms could indicate a serious condition that requires medical attention. Always prioritize your health and seek guidance if you have any concerns.
Warnings and Precautions
It's important to be aware of some key warnings when using this product. If you suspect an overdose, seek emergency medical help immediately or contact a Poison Control Center.
You should also stop using the product and call your doctor if you experience rectal bleeding or if you do not have a bowel movement after using it. These symptoms could indicate a serious health issue that needs attention. Always prioritize your health and safety by staying informed and proactive.
Overdose
It appears that there is no specific information available regarding overdosage for this medication. However, it’s important to be aware of the general signs of an overdose, which can include symptoms like extreme drowsiness, confusion, or difficulty breathing. If you suspect an overdose, it’s crucial to seek immediate medical help.
In case of an emergency, call your local emergency services or go to the nearest hospital. Always keep medications out of reach of children and follow the prescribed dosage to prevent any potential risks. If you have any concerns or questions about your medication, don’t hesitate to reach out to your healthcare provider for guidance.
Pregnancy Use
If you are pregnant or breastfeeding, it’s important to consult with a healthcare professional before using this medication. They can provide guidance on whether it’s safe for you and your baby. Always prioritize your health and the health of your child by seeking expert advice.
Lactation Use
If you are pregnant or breastfeeding, it’s important to consult with a healthcare professional before using any medication. This ensures that you understand any potential risks and can make informed decisions about your health and the health of your baby. Always prioritize open communication with your doctor regarding your breastfeeding journey.
Pediatric Use
When it comes to giving this medication to children, it's important to follow specific guidelines based on their age. For children aged 12 years and older, the maximum amount you can give in a 24-hour period is 10 fluid ounces, while those between 6 and 12 years should receive no more than 7 fluid ounces. For younger children aged 2 to under 6 years, the limit is 3 fluid ounces in a day. If your child is under 2 years old, you should consult a doctor before administering the medication.
Always keep this medication out of reach of children to prevent accidental ingestion. In the event of an overdose, seek medical help or contact a Poison Control Center immediately. Your child's safety is the top priority, so please adhere to these guidelines closely.
Geriatric Use
While there is no specific information available about the use of this medication in older adults, it’s important to approach any new treatment with caution. Since older adults may have different health needs and responses to medications, you should always consult with a healthcare provider before starting any new medication. They can help determine the right dosage and monitor for any potential side effects, ensuring that the treatment is safe and effective for you or your loved one.
Renal Impairment
If you have kidney problems, it's important to know that your medication dosage may need to be adjusted. This is because renal impairment (reduced kidney function) can affect how your body processes certain drugs. To ensure your safety, your healthcare provider will monitor your creatinine clearance (a test that measures how well your kidneys are filtering waste) regularly.
Additionally, regular tests to check your overall kidney function are recommended, especially if you have significant renal impairment. This close monitoring helps your doctor make any necessary changes to your treatment plan, ensuring that you receive the safest and most effective care.
Hepatic Impairment
If you have liver problems, it's important to know that the drug insert does not provide specific information about dosage adjustments, special monitoring, or precautions for your condition. This means that there are no tailored guidelines for how this medication may affect you if you have hepatic impairment (liver issues).
Always consult your healthcare provider for personalized advice and to discuss any concerns you may have regarding your liver health and medication use. They can help ensure that you receive the safest and most effective treatment based on your individual needs.
Drug Interactions
It's important to have open conversations with your healthcare provider about any medications or tests you may be taking. While there are no specific drug interactions or laboratory test interactions noted for this medication, your healthcare provider can help ensure that everything you are taking works well together and is safe for you.
Always feel free to ask questions and share your complete list of medications and any lab tests you may be undergoing. This way, you can receive the best possible care tailored to your needs.
Storage and Handling
To ensure the best performance of your product, store it at temperatures between 46°F and 86°F (8°C and 30°C). Keeping it within this range helps maintain its effectiveness and safety.
When handling the product, always do so with clean hands and in a clean environment to avoid contamination. If you have any specific disposal instructions, please follow them carefully to ensure safety and compliance.
Additional Information
No further information is available.
FAQ
What is Magnesium Citrate?
Magnesium Citrate is a saline laxative in an oral solution form that provides relief from occasional constipation. It has a lemon flavor and comes in a volume of 10 FL OZ (296 mL).
How does Magnesium Citrate work?
Magnesium Citrate works by producing a bowel movement generally within 1/2 to 6 hours after ingestion, helping to relieve occasional constipation.
What are the dosage recommendations for adults and children?
Adults and children 12 years and over can take 6.5 to 10 fl oz, with a maximum of 10 fl oz in 24 hours. For children aged 6 to under 12 years, the dosage is 3 to 7 fl oz, and for children aged 2 to under 6 years, it is 2 to 3 fl oz, with a maximum of 3 fl oz in 24 hours.
What should I do before using Magnesium Citrate?
You should shake the bottle well before using and drink a full glass (8 ounces) of liquid with each dose.
Are there any contraindications for using Magnesium Citrate?
There are no explicit contraindications mentioned, but you should stop use and ask a doctor if you experience rectal bleeding or failure to have a bowel movement after use.
What should I do in case of an overdose?
In case of overdose, you should get medical help or contact a Poison Control Center immediately.
Is Magnesium Citrate safe to use during pregnancy or breastfeeding?
If you are pregnant or breastfeeding, you should ask a health professional before using Magnesium Citrate.
How should I store Magnesium Citrate?
Store Magnesium Citrate at temperatures between 46° and 86°F (8° and 30°C) and keep it out of reach of children.
What should I monitor if I have renal impairment?
If you have renal impairment, you may need dosage adjustments, and your creatinine clearance should be monitored regularly.
Packaging Info
Below are the non-prescription pack sizes of Citroma (magnesium citrate). Columns show Packaging, Formulation Type, and Active Ingredient Strength.
Details | ||||
|---|---|---|---|---|
| Liquid | 1.745 g/29.6 mL | ||
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC:
Active ingredients
Inactive ingredients
| ||||
Drug Information (PDF)
This file contains official product information for Citroma, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.
Description
No description information is available for the specified drug.
Uses and Indications
This drug is indicated for the relief of occasional constipation (irregularity). It generally produces a bowel movement within 1/2 to 6 hours of administration.
Limitations of Use: There are no known teratogenic or nonteratogenic effects associated with this drug.
Dosage and Administration
The medication should be shaken well before use. It is recommended that patients drink a full glass (8 ounces) of liquid with each dose to ensure proper administration.
For adults and children aged 12 years and older, the dosage ranges from 6.5 to 10 fluid ounces, with a maximum limit of 10 fluid ounces within a 24-hour period.
For children aged 6 to under 12 years, the dosage is between 3 to 7 fluid ounces, not exceeding 7 fluid ounces in a 24-hour period.
For children aged 2 to under 6 years, the recommended dosage is 2 to 3 fluid ounces within a 24-hour timeframe, with a maximum of 3 fluid ounces in that period.
For children under 2 years of age, it is advised to consult a physician for appropriate dosing recommendations.
The medication may be administered as a single daily dose or divided into multiple doses as deemed appropriate by the healthcare provider.
Contraindications
Use is contraindicated in patients experiencing rectal bleeding or failure to have a bowel movement after use, as these symptoms may indicate a serious underlying condition. In such cases, it is essential to seek medical advice promptly.
Warnings and Precautions
In the event of an overdose, it is imperative to seek emergency medical assistance immediately or contact a Poison Control Center. Prompt action is crucial to ensure patient safety and effective management of the situation.
Patients should discontinue use and consult a healthcare professional if they experience rectal bleeding or fail to have a bowel movement after administration. These symptoms may indicate a serious underlying condition that requires further evaluation and intervention.
Healthcare providers are advised to monitor patients closely for these signs and symptoms to ensure timely management and to mitigate potential risks associated with the use of this product.
Side Effects
Patients should discontinue use and consult a healthcare professional if they experience rectal bleeding or failure to have a bowel movement after use, as these symptoms may indicate a serious underlying condition.
Drug Interactions
There are currently no documented drug interactions associated with this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.
Packaging & NDC
Below are the non-prescription pack sizes of Citroma (magnesium citrate). Columns show Packaging, Formulation Type, and Active Ingredient Strength.
Details | ||||
|---|---|---|---|---|
| Liquid | 1.745 g/29.6 mL | ||
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC:
Active ingredients
Inactive ingredients
| ||||
Pediatric Use
Pediatric patients aged 12 years and older may receive a dosage of 6.5 to 10 fl oz, with a maximum limit of 10 fl oz in a 24-hour period. For children aged 6 to under 12 years, the recommended dosage ranges from 3 to 7 fl oz, not exceeding 7 fl oz in 24 hours. In children aged 2 to under 6 years, the dosage is 2 to 3 fl oz, with a maximum of 3 fl oz in 24 hours. For infants under 2 years of age, it is advised to consult a doctor before administration.
It is crucial to keep this product out of reach of children. In the event of an overdose, immediate medical assistance should be sought, or contact a Poison Control Center without delay.
Geriatric Use
There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy.
Pregnancy
Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. The potential risks and benefits must be carefully weighed, as the effects on fetal outcomes and lactation are not fully established. It is essential for women of childbearing potential to seek medical advice to ensure safe use during pregnancy and lactation.
Lactation
Lactating mothers are advised to consult a health professional prior to using this medication. There is currently no available data regarding the excretion of this medication in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.
Renal Impairment
Patients with renal impairment may necessitate dosage adjustments based on their level of kidney function. It is essential for healthcare professionals to monitor creatinine clearance in patients with reduced renal function to ensure appropriate dosing. Regular renal function tests are recommended for patients with kidney problems to assess their renal status. Additionally, special monitoring is required for patients with significant renal impairment to mitigate potential risks associated with medication use.
Hepatic Impairment
Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.
Overdosage
There is currently no specific information available regarding overdosage for this medication. Healthcare professionals are advised to monitor patients closely for any signs of adverse effects or symptoms that may arise from excessive dosing.
In the event of suspected overdosage, it is recommended that healthcare providers initiate supportive care and symptomatic treatment as necessary. Patients should be evaluated for potential complications, and appropriate interventions should be implemented based on clinical judgment.
For further guidance, healthcare professionals may refer to established protocols for managing drug overdosage or consult a poison control center.
Nonclinical Toxicology
No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.
Postmarketing Experience
No postmarketing experience details are available in the insert text.
Patient Counseling
Healthcare providers should advise patients to seek immediate medical assistance or contact a Poison Control Center in the event of an overdose. It is important for patients to be aware of the signs that warrant discontinuation of the product; they should stop use and consult a doctor if they experience rectal bleeding or fail to have a bowel movement after use, as these may indicate a serious condition.
Patients should be encouraged to consult with their healthcare provider before using this product if they have any of the following conditions: kidney disease, a magnesium-restricted diet, abdominal pain, nausea, or vomiting. Additionally, patients should be informed that a sudden change in bowel habits persisting for more than two weeks or the use of a laxative for longer than one week also necessitates a discussion with their doctor.
Furthermore, patients should be instructed to consult a doctor or pharmacist prior to use if they are currently taking any other medications. It is essential to inform patients that this product should be taken at least two hours before or after other drugs, as laxatives may influence the effectiveness of concurrent medications.
Storage and Handling
The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product at temperatures ranging from 46° to 86°F (8° to 30°C) to maintain its integrity and efficacy. Proper storage conditions must be adhered to, ensuring that the product is kept within the specified temperature range to prevent degradation.
Additional Clinical Information
No further data are available.
Drug Information (PDF)
This file contains official product information for Citroma, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.